Learn More
Although articulatory deficits represent an important manifestation of dysarthria in Parkinson's disease (PD), the most widely used methods currently available for the automatic evaluation of speech performance are focused on the assessment of dysphonia. The aim of the present study was to design a reliable automatic approach for the precise estimation of(More)
Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow(More)
Recently, based on voice cepstral analysis, Benba et al. (IEEE T. Neur. Sys. Reh., vol. 24, pp. 1100-1108, 2016) have reported discrimination between patients with Parkinson's disease and different neurological disorders with high classification accuracy up to 90%. Using the same approach, we were able to experimentally separate two groups of normal healthy(More)
PURPOSE Series of N,N-dimethylamino acid esters was synthesized to study their transdermal permeation-enhancing potency, biodegradability and reversibility of action. Effects of chirality, linking chain length and polyfluorination were investigated. MATERIALS AND METHODS In vitro activities were evaluated using porcine skin and four model(More)
Transdermal permeation enhancers are compounds that temporarily increase drug flux through the skin by interacting with constituents of the stratum corneum. Transkarbam 12 (T12) is a highly active, broad-spectrum, biodegradable enhancer with low toxicity and low dermal irritation. We show here that T12 acts by a dual mechanism of action. The first part of(More)
A series of transdermal permeation enhancers based on dicarboxylic acid esters was studied. Single-chain amphiphiles were markedly more effective than the double-chain ones. Monododecyl maleate, that is a cis derivative, was a more potent enhancer than its trans isomer, while the activity of succinates strongly depended on the donor vehicle. No difference(More)
The purpose of this study is to analyze the economic burden of persons with Alzheimer's disease (AD) and Parkinson's disease (PD) in Europe. On the basis of available data about the number of persons with dementia, their prevalence, and treatment and care costs, a mean cost burden is estimated for the year of 2030 and for the year of 2050 in Europe. The(More)
In this work we present the method that we have adopted in order to leave in search of the speaker through different measures of jitter and shimmer are measures of the fundamental frequency and of amplitude variations cycle to cycle. We have used these two indices as they characterize some aspects concerning the Voice individuals, so it helps us to have a(More)
Transkarbam 12, an ammonium carbamate formed by the reaction of dodecyl 6-aminohexanoate with carbon dioxide, is a highly active, broad-spectrum, nontoxic, and nonirritant transdermal permeation enhancer. It probably acts by a dual mechanism: a part of its activity is associated with the carbamic acid salt and/or its decomposition in the acidic stratum(More)